James E. Rouse is President at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT). They have made 3 open-market trades across 1 company since 2006, most recently 2011-09-15.
CIK 0001259992
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $19K since 2011, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HRT | 16,839 | $242K |
Shares reported on the most recent Form 4, priced at the 2011-09-19 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.